| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adenosine deaminase | 0.440 | 0.885 | 2.9E-12 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
synapse defective Rho GTPase homolog 1 | 1.000 | 0.115 | 0.77 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
actin binding LIM protein family member 2 | 0.890 | 0.231 | 4.6E-03 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
acyl-CoA thioesterase 9 | 0.931 | 0.154 | 6.8E-09 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
ATP binding cassette subfamily D member 2 | 0.711 | 0.500 | 4.7E-06 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
ADAM metallopeptidase domain 11 | 0.670 | 0.538 | 1.0E-05 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
ATP binding cassette subfamily B member 5 | 0.623 | 0.538 | 1.5E-37 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
EPH receptor A3 | 0.497 | 0.692 | 1.2E-05 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
acetyl-CoA carboxylase beta | 0.644 | 0.654 | 7.6E-47 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
ADAM metallopeptidase domain 19 | 0.659 | 0.538 | 6.8E-05 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
ATP binding cassette subfamily A member 12 | 0.610 | 0.654 | 2.9E-15 |
|
disease | 0.300 | None | 0 | 1 | |||||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.100 | None | 0.988 | 85 | 1 | 1998 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.969 | 32 | 1 | 1996 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.100 | None | 0.950 | 20 | 1 | 1995 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 20 | 0 | 2007 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.100 | None | 0.947 | 19 | 0 | 2004 | 2020 | ||||||||
|
SMAD family member 4 | 0.401 | 0.808 | 1.00 |
|
disease | 0.100 | None | 1.000 | 19 | 0 | 2001 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 1.000 | 17 | 0 | 2007 | 2019 | ||||||||
|
microRNA 21 | 0.363 | 0.846 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2010 | 2019 | |||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2007 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 2007 | 2019 | ||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
disease | 0.100 | None | 0.917 | 12 | 0 | 2017 | 2019 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 2010 | 2019 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.100 | None | 1.000 | 11 | 1 | 2000 | 2019 | ||||||||
|
pancreatic and duodenal homeobox 1 | 0.530 | 0.654 | 1.8E-02 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2004 | 2019 |